Variant report
Variant | esv2640340 |
---|---|
Chromosome Location | chr4:86238297-86239756 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528116268 | chr4:86238314-86238315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs77454062 | chr4:86238353-86238354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530879359 | chr4:86238390-86238391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560934594 | chr4:86238408-86238409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531954579 | chr4:86238458-86238459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528544682 | chr4:86238505-86238506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183179260 | chr4:86238516-86238517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs72955756 | chr4:86238544-86238545 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs532886601 | chr4:86238551-86238552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs901122 | chr4:86238580-86238581 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs373797703 | chr4:86238627-86238628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113579964 | chr4:86238688-86238689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192678916 | chr4:86238723-86238724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115291196 | chr4:86238771-86238772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185730637 | chr4:86238797-86238798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571584354 | chr4:86238847-86238848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199643307 | chr4:86238922-86238923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537133045 | chr4:86238946-86238947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs116120211 | chr4:86238954-86238955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11931292 | chr4:86238964-86238965 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs79628384 | chr4:86238979-86238980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs66483940 | chr4:86238980-86238981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs11931323 | chr4:86239048-86239049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368781542 | chr4:86239058-86239059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4423866 | chr4:86239068-86239069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572090677 | chr4:86239096-86239097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189270600 | chr4:86239118-86239119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377274211 | chr4:86239165-86239166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138676966 | chr4:86239179-86239180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567448068 | chr4:86239189-86239190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576230979 | chr4:86239310-86239311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138097840 | chr4:86239388-86239389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536586436 | chr4:86239439-86239440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543148582 | chr4:86239457-86239458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565514949 | chr4:86239470-86239471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370510582 | chr4:86239503-86239504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553185630 | chr4:86239574-86239575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566699508 | chr4:86239647-86239648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559769659 | chr4:86239657-86239658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530050797 | chr4:86239686-86239687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539837975 | chr4:86239744-86239745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Prostate cancer | 16573809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:86237800-86238800 | Enhancers | Adipose Nuclei | Adipose |
2 | chr4:86238800-86239200 | Weak transcription | Adipose Nuclei | Adipose |
3 | chr4:86239200-86240200 | Enhancers | Adipose Nuclei | Adipose |
4 | chr4:86239400-86240200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr4:86239400-86240200 | Enhancers | NHEK | skin |
6 | chr4:86239400-86240400 | Enhancers | HMEC | breast |